title: Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy:  a case series.
abstract: Left ventricular assist device (LVAD) therapy has been used primarily in patients with end-stage dilated cardiomyopathy (DCM), and patients with hypertrophic cardiomyopathy (HCM) are generally excluded. We compared outcomes in 3 HCM patients with 36 DCM patients. While HCM patients had smaller left ventricular end-diastolic dimensions, average pump flows for the two groups were similar. All patients had marked improvement in mean pulmonary arterial pressures and cardiac index at 5 months. This analysis shows that patients with end-stage heart failure resulting from HCM do benefit from centrifugal cfLVAD therapy in the short to medium term.
authors: Heart Failure and Transplant Unit, St. Vincent's Hospital, Darlinghurst, Australia.
authors: Kavitha
authors: K
authors: Muthiah
authors: Justin
authors: J
authors: Phan
authors: Desiree
authors: D
authors: Robson
authors: Peter S
authors: PS
authors: Macdonald
authors: Anne M
authors: AM
authors: Keogh
authors: Eugene
authors: E
authors: Kotlyar
authors: Emily
authors: E
authors: Granger
authors: Kumud
authors: K
authors: Dhital
authors: Phillip
authors: P
authors: Spratt
authors: Paul
authors: P
authors: Jansz
authors: Christopher S
authors: CS
authors: Hayward
mesh_terms: D000328:Adult; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000503:physiopathology / Q000601:surgery*; D004452:Echocardiography; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D016277:Ventricular Function, Left